BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37367650)

  • 1. Substitution of D-Arginine at Position 11 of α-RgIA Potently Inhibits α7 Nicotinic Acetylcholine Receptor.
    Wu Y; Zhang J; Ren J; Zhu X; Li R; Zhangsun D; Luo S
    Mar Drugs; 2023 May; 21(6):. PubMed ID: 37367650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
    Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
    J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
    Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
    Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
    Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
    J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoarginine Peptides, a New Family of Nicotinic Acetylcholine Receptor Inhibitors.
    Lebedev DS; Kryukova EV; Ivanov IA; Egorova NS; Timofeev ND; Spirova EN; Tufanova EY; Siniavin AE; Kudryavtsev DS; Kasheverov IE; Zouridakis M; Katsarava R; Zavradashvili N; Iagorshvili I; Tzartos SJ; Tsetlin VI
    Mol Pharmacol; 2019 Nov; 96(5):664-673. PubMed ID: 31492697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
    Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
    Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
    Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
    J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives.
    Armishaw C; Jensen AA; Balle T; Clark RJ; Harpsøe K; Skonberg C; Liljefors T; Strømgaard K
    J Biol Chem; 2009 Apr; 284(14):9498-512. PubMed ID: 19131337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor.
    Jiang S; Tae HS; Xu S; Shao X; Adams DJ; Wang C
    Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28598389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors.
    Tae HS; Gao B; Jin AH; Alewood PF; Adams DJ
    Biochem Pharmacol; 2021 Aug; 190():114638. PubMed ID: 34062129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short framework-III (mini-M-2) conotoxin from the venom of a vermivorous species, Conus archon, inhibits human neuronal nicotinic acetylcholine receptors.
    Hernández-Sámano AC; Falcón A; Zamudio F; Michel-Morfín JE; Landa-Jaime V; López-Vera E; Jeziorski MC; Aguilar MB
    Peptides; 2022 Jul; 153():170785. PubMed ID: 35307452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
    Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
    J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Crystal Structures of RgIA4 in Complex with
    Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
    Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
    Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
    Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
    Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.
    Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA
    J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.
    AlSharari SD; Toma W; Mahmood HM; Michael McIntosh J; Imad Damaj M
    Eur J Pharmacol; 2020 Sep; 883():173320. PubMed ID: 32645334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist.
    Whiteaker P; Marks MJ; Christensen S; Dowell C; Collins AC; McIntosh JM
    J Pharmacol Exp Ther; 2008 Jun; 325(3):910-9. PubMed ID: 18323456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
    Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
    Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.